GXLV holdings
As of , GXLV (S&P US Health Care Sel. Sec. UCITS ETF Accum Ptg USD, ISIN IE00BWBXM617) has 60 holdings on our record, together 100.0% of the fund; the ten largest make up 60.8%. Weights are shares of the whole fund.
Largest holdings
| Rank# | Holding | Weight as a percentage of the fund |
|---|---|---|
| 1 | Eli Lilly andLLY | 15.17% |
| 2 | Johnson & JohnsonJNJ | 10.45% |
| 3 | AbbVieABBV | 7.57% |
| 4 | MerckMRK | 5.87% |
| 5 | UnitedHealth GroupUNH | 5.40% |
| 6 | Thermo Fisher ScientificTMO | 4.09% |
| 7 | AmgenAMGN | 3.73% |
| 8 | Gilead SciencesGILD | 3.03% |
| 9 | Abbott LaboratoriesABT | 2.80% |
| 10 | PfizerPFE | 2.66% |
Source: SPDR, holdings as published, as of
More of the portfolio
The fund publishes 60 holdings; the ten largest make up 60.8% of it. The fund's portfolio is also split by currency.
Create a free account to see the full holdings list and the currency, maturity and credit-quality breakdowns
Sign-up takes an email address. There is no card to enter and nothing to pay.
More:GXLV: key facts, returns and chargesCompare what it holds with another fundHoldings overlapHow overlap is measured
Holdings and weights are as published by SPDR on 30/09/2026 and change as the fund trades.